Ellagic acid inhibits nucleoside diphosphate kinase-B activity.
Malmquist
N A
NA
Department of Pharmacology, University of Nevada School of Medicine, Reno, Nevada 89557, USA.
Anzinger
J J
JJ
Hirzel
D
D
Buxton
I L
IL
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000201:enzymology; D004610:Ellagic Acid / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005260:Female; D006801:Humans; D009389:Neovascularization, Pathologic / Q000473:pathology*; D009701:Nucleoside-Diphosphate Kinase / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D004610:Ellagic Acid; D009701:Nucleoside-Diphosphate Kinase